Evidence map›Paper›PMID 31095969›Full record

ArticleExperimental gerontology2019

Plasma matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs and aging and lifelong exercise adaptations in ventricular and arterial stiffness.

Graeme Carrick-Ranson, Francis G Spinale, Paul S Bhella, Satyam Sarma, Shigeki Shibata, Naoki Fujimoto, Jeffrey L Hastings, Benjamin D Levine

Open access · greenAbstract read
In one paragraph

Article in Experimental gerontology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. MicroRNAs regulating signaling pathways in cardiac fibrosis: potential role of the exercise training.American journal of physiology. Heart and circulatory physiology · 2024
    Review
  4. Review
  5. Vascular Ageing and Aerobic Exercise.International journal of environmental research and public health · 2021
    Review
  6. Modulation of Cardiac Fibrosis in and Beyond Cells.Frontiers in molecular biosciences · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Graeme Carrick-RansonInstitute for Exercise and Environmental Medicine, Texas Health Presbyterian Dallas, University of Texas Southwestern Medical Center, Dallas, TX, USA; The School of Health Sciences, University of South Australia, Adelaide, Australia.
Francis G SpinaleUniversity of South Carolina School of Medicine and WJB Dorn Veteran Affairs Hospital, Columbia, SC, USA.
Paul S BhellaInstitute for Exercise and Environmental Medicine, Texas Health Presbyterian Dallas, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Satyam SarmaInstitute for Exercise and Environmental Medicine, Texas Health Presbyterian Dallas, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Shigeki ShibataInstitute for Exercise and Environmental Medicine, Texas Health Presbyterian Dallas, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Naoki FujimotoInstitute for Exercise and Environmental Medicine, Texas Health Presbyterian Dallas, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Jeffrey L HastingsInstitute for Exercise and Environmental Medicine, Texas Health Presbyterian Dallas, University of Texas Southwestern Medical Center, Dallas, TX, USA; Veteran Affairs North Texas Health Care System, Dallas, TX, USA.
Benjamin D LevineInstitute for Exercise and Environmental Medicine, Texas Health Presbyterian Dallas, University of Texas Southwestern Medical Center, Dallas, TX, USA. Electronic address: BenjaminLevine@Texashealth.org.
Institute for Exercise and Environmental Medicine · USSouthwestern Medical Center · USThe University of Texas Southwestern Medical Center · USWm. Jennings Bryan Dorn VA Medical Center · US

Funding

Aging Fitness & Failure: Mechanisms of Diastolic DysfunctionR01AG017479 · NIA · UT SOUTHWESTERN MEDICAL CENTER · PI LEVINE, BENJAMIN D · 2001 to 2016
$7.8M
NIA NIH HHS R01 AG017479
6 · The paper itself

Abstract

The age-associated increase in cardiac and central arterial stiffness is attenuated with lifelong (>25 years) endurance exercise in a dose-dependent manner. Remodelling of the extracellular matrix of cardiovascular structures may underpin these lifelong exercise adaptations in structural stiffness. The primary aim was to examine whether matrix metalloproteinases (MMPs) and tissue inhibitors of matrix metalloproteinases (TIMPs) levels are associated with aging and lifelong exercise-related changes in cardiac and central arterial stiffness. Plasma MMPs and TIMPs, left ventricular (LV) (LV stiffness constant) and central arterial stiffness (pulse wave velocity) were examined in healthy adults stratified into five groups based on age and lifelong weekly exercise frequency: (1) young sedentary adults (28-50 years), and older adults (>60 years) who had performed either: (a) sedentary (0-1 sessions/week), (b) casual (2-3 sessions/week), (c) committed (4-5 sessions/week) or (d) athletic (≥6 sessions/week) frequency of exercise. MMP-1 was significantly lower in young compared to older sedentary (p = 0.049). Except for TIMP-2 (p = 0.018 versus committed) and the ratio of MMP-2/TIMP-4 (p = 0.047 versus committed), MMP and TIMP expression was not significantly different in lifelong exercise groups (≥casual) compared to the older sedentary group. MMP-1, -3 had a weak positive relationship with central PWV (r = 0.17-0.25, p ≤ 0.050) but there were no significant relationships between MMPs or TIMPs and LV stiffness constant (p ≥ 0.148). In conclusion, there was not a clear or consistent difference in plasma MMPs and TIMPs with lifelong exercise dose despite exhibiting lower cardiovascular stiffness at the highest exercise levels.

Indexed as

Adaptation, PhysiologicalAgedAgingCardiovascular Physiological PhenomenaCorrelation of DataExerciseExtracellular MatrixFemaleHumansMaleMatrix Metalloproteinase InhibitorsMatrix MetalloproteinasesMiddle AgedVascular StiffnessMatrix Metalloproteinase InhibitorsMatrix MetalloproteinasesAgingExerciseMatrix metalloproteinasesStiffnessTissue inhibitors of matrix metalloproteinases

Identifiers

PMID31095969
PMCPMC6559842
OpenAlexW2946672503

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.